Shorts

Mathew D. Sorensen, MD, MS, FACS, on how Break Wave may reduce stent use

Robert S. Svatek, MD, MSCI, on the global evolution of BCG

Meri-Margaret Deoudes, CFRE, on bladder cancer diagnosis is often delayed in women

Pooja Ghatalia, MD, discusses ctDNA’s utility in MIBC

Stacy Loeb, MD, MSc, PhD (hon), on microplastics in prostate tumors

Melissa Moran, DO, on prescribing patterns for postmenopausal female HSDD

Ezra Margolin, MD, on antibiotic use in patients with stones

Jessica Yih, MD, discusses GLP-1RAs and vulvar health

María Teresa Bourlon, MD, MS, FASCO, on prostate cancer research at ASCO GU 2026

Kiera Liblik, MD, MSc, discusses inconsistent terminology in medical research

Jonathan Yu, MD, on the effect of robotics on vesicourethral anastomotic leaks

Christopher Filson, MD, on exploring bladder cancer biomarkers

Alex Tatem, MD, outlines the safety of hyaluronic acid penile injections

What are some benefits of multiport robotic partial nephrectomy?

The evolution of testicular cancer survivorship care

How Break Wave allows for patient participation in kidney stone treatment

Christopher Filson, MD, shares data on study of CxBladder Triage

Veda Giri, MD, on patient education for genetic testing

Amy Luckenbaugh, MD, on advances in urologic oncology

World Cancer Day: Honoring Patient Resilience and Recent Advances in Urologic Oncology

Kate Kraft, MD, discusses how to build leadership presence as an introvert

Amanda North, MD, discusses imposter syndrome and reframing your thinking

Mathew D. Sorensen, MD, MS, FACS, on how Break Wave lithotripsy works without anesthesia

Farah Rahman, MD, discusses wearable tech in measuring burnout

Ridwan I. Alam, MD, MPH, on PHI’s role in prostate cancer risk stratification

Aleece Fosnight, MSPAS, PA-C, on how vaginal estrogen cream helps patients

The UroOnc Minute: Adam Weiner, MD, and Jeremy Teoh, MBBS, on en bloc resection of bladder tumor

Sudha Jayaraman, MD, on how AI can help mitigate physician burnout

Daniel Antonio González Padilla, MD, on the end points of the CREST and POTOMAC trials

Ridwan I. Alam, MD, MPH, on his approach to prostate cancer screening